ANG-PB Financials

ANG-PB

Trailing 12 months to March 31, 2026

Revenue $7.2B -26.0% YoY

Net Income $738.0M +80.0% YoY

Free Cash Flow $2.7B YoY not available

Operating Cash Flow $2.8B -4.1% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ANG-PB SEC filings page.

ANG-PB (ANG-PB) reported $7.2B in revenue over the twelve months to Mar 31, 2026, down 26.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ANG-PB FY2025 2026-10-22

The balance sheet expanded rapidly, but profitability weakened while cash generation improved and liabilities remained the dominant funding source.

Revenue was nearly unchanged from FY2024 to FY2025, while net income fell 26.9%. Meanwhile, operating cash flow rose 10.3% and free cash flow rose 9.5%, so cash generation strengthened even as accounting profit weakened.

The business is highly balance-sheet intensive: FY2025 liabilities of $120.6B stood against assets of $130.3B. That left equity at $9.7B, with liabilities comprising 92.6% of assets, a funding structure with limited equity relative to total resources. The mix also became more liability-heavy, rising from 91.7% of assets in FY2024.

Assets grew 7.5% in FY2025, but capital expenditures were only $61M. Free cash flow reached $2.7B, indicating reported expansion was not driven by heavy internal reinvestment. Interest expense rose 10.9% to $183M, while ROA fell to 0.4%, showing the enlarged asset base produced less earnings efficiency.

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for ANG-PB, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial

4/6

ANG-PB passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality Cash-Backed

5.22x

For every $1 of reported earnings, ANG-PB generates $5.22 in operating cash flow ($2.8B OCF vs $533.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.6B

YoY-15.3%

QoQ+18.2%

ANG-PB generated $1.6B in revenue in Q1 2026. This represents a decrease of 15.3% from the same quarter a year earlier. Against the prior quarter it is up 18.2%.

Net Income

-$1.0M

YoYn/m

QoQ-100.3%

ANG-PB reported a net loss of $1.0M in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 100.3%.

EBITDA

Not reported for Q1 2026.

EPS (Diluted)

Not reported for Q1 2026.

Cash & Balance Sheet

Free Cash Flow

$688.0M

YoY+3.3%

QoQ-39.0%

ANG-PB generated $688.0M in free cash flow in Q1 2026, representing cash available after capex. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is down 39.0%.

Cash & Debt

$8.9B

YoY+18.8%

QoQ-23.4%

5Y CAGR-4.2%

10Y CAGR+28.9%

ANG-PB held $8.9B in cash against $3.0B in long-term debt as of Q1 2026.

Shares Outstanding

10,000

YoY0.0%

ANG-PB had 10,000 shares outstanding in Q1 2026. That is unchanged from the same quarter a year earlier.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Net Margin

-0.1%

YoY+10.8pp

QoQ-27.2pp

ANG-PB's net profit margin was -0.1% in Q1 2026, showing the share of revenue converted to profit. This is up 10.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 27.2 percentage points.

Return on Equity

0.0%

YoY+2.0pp

QoQ-3.8pp

ANG-PB's quarterly ROE was 0.0% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is up 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.8 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

Capital Expenditures

$11.0M

YoY+120.0%

QoQ-42.1%

ANG-PB invested $11.0M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 120.0% from the same quarter a year earlier. Against the prior quarter it is down 42.1%.

R&D Spending

Not reported for Q1 2026.

Share Buybacks

Not reported for Q1 2026.

ANG-PB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ANG-PB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$7.2B	$7.5B-0.4%	$7.5B+121.5%	$3.4B+140.1%	$1.4B-61.7%	$3.7B+52.2%	$2.4B-30.0%	$3.5B+123.9%	$1.5B-60.2%	$3.9B+75.3%	$2.2B+46.2%	$1.5B-30.0%	$2.2B-16.9%	$2.6B+58.0%	$1.7B+32.6%	$1.2B
Interest Expense	$188.0M	$183.0M+10.9%	$165.0M+259.6%	$45.9M+43.0%	$32.1M+25.5%	$25.6M+0.1%	$25.6M+0.1%	$25.5M+0.1%	$25.5M-16.0%	$30.4M+7.5%	$28.2M-2.1%	$28.8M-20.7%	$36.4M-6.4%	$38.9M+36.5%	$28.5M-10.0%	$31.6M
Income Tax	$59.0M	-$20.0Mn/m	-$199.0M-562.8%	$43.0M-91.6%	$511.1M+241.3%	$149.8M+3.6%	$144.5M+108.0%	$69.5M-35.5%	$107.7M-23.9%	$141.6M+201.3%	$47.0M-60.0%	$117.5M+67.7%	$70.0M-48.5%	$136.0M+382.6%	$28.2M-39.6%	$46.7M
Net Income	$738.0M	$533.0M-26.9%	$729.0M+86.0%	$392.0M-79.6%	$1.9B+247.2%	$553.0M-17.6%	$671.5M+172.9%	$246.1M-46.3%	$458.0M+162.3%	$174.6M+109.8%	$83.2M-62.1%	$219.8M+74.4%	$126.0M-50.2%	$253.3M+338.2%	$57.8M-33.0%	$86.2M
EPS (Basic)	N/A	N/A	N/A	$2.10	$20.72+281.6%	$5.43-21.6%	$6.93+156.7%	$2.70-46.7%	$5.07+158.7%	$1.96+100.0%	$0.98-64.7%	$2.78+64.5%	$1.69-56.2%	$3.86+310.6%	$0.94-35.2%	$1.45
EPS (Diluted)	—	N/A	N/A	$2.06	$20.50+280.3%	$5.39-21.9%	$6.90+157.5%	$2.68-46.5%	$5.01+159.6%	$1.93+99.0%	$0.97-64.3%	$2.72+72.2%	$1.58-53.3%	$3.38+279.8%	$0.89-35.0%	$1.37
Diluted Shares (Avg)	N/A	N/A	N/A	81M	92M-3.1%	94M+2.3%	92M+0.7%	92M+0.4%	91M+1.2%	90M+5.5%	86M+5.7%	81M+1.3%	80M+6.5%	75M+14.3%	66M+3.2%	64M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$1.6B-15.3%	$1.4B-63.5%	$2.1B+2.7%	$2.2B+3.4%	$1.9B+13.1%	$3.7B	$2.0B+58.5%	$2.1B+42.1%
Interest Expense	$49.0M+11.4%	$43.0M-30.0%	$47.0M-4.1%	$49.0M+14.0%	$44.0M+279.9%	$61.4M	$49.0M+308.2%	$43.0M+283.0%
Income Tax	$17.0Mn/m	-$115.0M-168.9%	$119.0Mn/m	$38.0Mn/m	-$62.0M-313.8%	$167.0M	-$77.0M-955.6%	-$289.0M-1476.2%
Net Income	-$1.0Mn/m	$368.0M-43.3%	$219.0Mn/m	$152.0M-40.4%	-$206.0M-282.3%	$649.0M	-$288.0M-633.3%	$255.0M+152.5%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

ANG-PB Balance Sheet

ANG-PB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$130.3B+7.5%	$121.2B+237.8%	$35.9B-51.0%	$73.2B-9.1%	$80.5B+12.4%	$71.7B+2.9%	$69.7B+13.1%	$61.6B-0.7%	$62.0B+10.7%	$56.1B+14.3%	$49.0B+11.5%	$44.0B+11.0%	$39.6B+12.8%	$35.1B+13.8%	$30.9B
Cash & Equivalents	$11.7B+7.3%	$10.9B+240.4%	$3.2B+66.3%	$1.9B-57.4%	$4.5B-50.4%	$9.1B+296.6%	$2.3B+565.9%	$344.4M-76.0%	$1.4B+81.2%	$791.3M+98.9%	$397.7M-43.3%	$701.5M-21.8%	$897.5M-29.2%	$1.3B+213.3%	$405.0M
Goodwill	$748.0M0.0%	$748.0M+769.8%	$86.0M0.0%	$86.0M+95.5%	$44.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$120.6B+8.4%	$111.2B+270.8%	$30.0B-57.7%	$70.8B-2.7%	$72.8B+11.4%	$65.3B+0.3%	$65.1B+10.0%	$59.2B+0.1%	$59.2B+10.1%	$53.8B+14.2%	$47.1B+12.5%	$41.8B+9.4%	$38.2B+14.4%	$33.4B+13.4%	$29.5B
Long-Term Debt	$3.0B-0.2%	$3.0B+98.1%	$1.5B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$9.7B-3.6%	$10.0B+231.7%	$3.0B+28.7%	$2.3B-69.6%	$7.7B+21.9%	$6.3B+43.4%	$4.4B+84.1%	$2.4B-15.6%	$2.9B+24.4%	$2.3B+17.8%	$1.9B-9.1%	$2.1B+54.5%	$1.4B-19.5%	$1.7B+22.1%	$1.4B
Retained Earnings	$1.8B+29.7%	$1.4B+89.4%	$716.0M-84.7%	$4.7B+65.0%	$2.8B+19.9%	$2.4B+33.9%	$1.8B+14.1%	$1.5B+24.5%	$1.2B+13.9%	$1.1B+6.0%	$1.0B+24.4%	$829.2M+15.5%	$718.2M+50.4%	$477.5M+11.3%	$429.0M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$130.4B+5.6%	$130.3B+7.5%	$130.6B+5.6%	$126.3B+6.5%	$123.4B+52.8%	$121.2B+237.8%	$123.7B+61.2%	$118.6B+52.8%
Cash & Equivalents	$8.9B+18.8%	$11.7B+7.3%	$11.6B-16.6%	$12.1B-12.9%	$7.5B-44.3%	$10.9B+240.4%	$13.9B+36.2%	$13.9B+177.9%
Goodwill	$748.0M-4.5%	$748.0M0.0%	$783.0M+3.8%	$783.0M+3.8%	$783.0M	$748.0M+769.8%	$754.0M	$754.0M
Total Liabilities	$121.0B+6.7%	$120.6B+8.4%	$119.6B+5.2%	$116.1B+6.2%	$113.4B+46.1%	$111.2B+270.8%	$113.7B+52.3%	$109.4B+45.7%
Long-Term Debt	$3.0B-0.2%	$3.0B-0.2%	$3.4B+16.6%	$3.0B+19.3%	$3.0B	$3.0B+98.1%	$3.0B	$2.5B
Total Equity	$9.4B-6.5%	$9.7B-3.6%	$11.0B+10.0%	$10.2B+10.4%	$10.0B+219.1%	$10.0B+231.7%	$10.0B+386.1%	$9.3B+259.9%
Retained Earnings	$1.8B+55.0%	$1.8B+29.7%	$1.5B+108.7%	$1.3B+27.7%	$1.1B-78.1%	$1.4B+89.4%	$709.0M-86.7%	$1.0B-79.3%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

ANG-PB Cash Flow Statement

ANG-PB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$2.8B	$2.8B+10.3%	$2.5B+112.6%	$1.2B-42.0%	$2.0B-51.7%	$4.2B+224.4%	$1.3B-61.1%	$3.4B+7660.6%	$43.2M-97.8%	$1.9B+35.8%	$1.4B+180.6%	$504.8M-28.7%	$707.8M-18.0%	$862.7M+10.0%	$784.3M+182.3%	$277.8M
Depreciation & Amortization	N/A	$170.0M+123.7%	$76.0M+300.0%	$19.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$9.5M-48.4%	$18.4M-0.2%	$18.4M-3.0%	$19.0M
Stock-Based Compensation	N/A	N/A	N/A	$29.3M+85.1%	$15.8M-35.7%	$24.6M+140.8%	$10.2M-9.6%	$11.3M+1.8%	$11.1M+71.7%	$6.5M-3.4%	$6.7M-9.2%	$7.4M+108.0%	$3.5M-66.2%	$10.5M+59.9%	$6.6M-29.8%	$9.3M
Capital Expenditures	$67.0M	$61.0M+64.9%	$37.0M-26.1%	$50.1M+22.3%	$41.0M+126.2%	$18.1M+36.8%	$13.2M+229.2%	$4.0M-6.1%	$4.3M-10.9%	$4.8M+301.8%	$1.2M-8.8%	$1.3M-2.9%	$1.4M+42.6%	$948K+28.5%	$738K-86.0%	$5.3M
Free Cash Flow	$2.7B	$2.7B+9.5%	$2.5B+118.8%	$1.1B-43.3%	$2.0B-52.5%	$4.2B+226.3%	$1.3B-61.4%	$3.3B+8504.6%	$38.9M-98.0%	$1.9B+35.6%	$1.4B+181.1%	$503.5M-28.7%	$706.4M-18.0%	$861.7M+10.0%	$783.6M+187.5%	$272.5M
Investing Cash Flow	-$8.3B	-$9.7B-486.7%	$2.5Bn/m	-$1.3Bn/m	-$2.5Bn/m	-$6.2B-221.2%	$5.1Bn/m	-$3.1Bn/m	-$2.4Bn/m	-$2.6Bn/m	-$4.5Bn/m	-$5.6Bn/m	-$2.9Bn/m	-$3.9Bn/m	-$2.1Bn/m	-$3.6B
Financing Cash Flow	$6.9B	$7.3B+135.6%	$3.1B+61.4%	$1.9Bn/m	-$2.2Bn/m	-$2.6B-815.9%	$362.5M-78.1%	$1.7B+29.6%	$1.3B-2.8%	$1.3B-62.3%	$3.5B-27.1%	$4.8B+133.3%	$2.0B-22.7%	$2.6B+19.8%	$2.2B-29.5%	$3.1B
Dividends Paid	$36.0M	$49.0M+48.5%	$33.0M-95.6%	$750.0M+2383.0%	$30.2M-4.0%	$31.4M+9.0%	$28.9M+5.7%	$27.3M+8.1%	$25.3M+9.1%	$23.1M+9.7%	$21.1M+18.1%	$17.9M+19.0%	$15.0M+18.8%	$12.6M+37.4%	$9.2M+33.1%	$6.9M
Share Buybacks	N/A	N/A	N/A	$309.4M-45.4%	$566.6M+469.9%	$99.4M-39.8%	$165.1Mn/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$16Kn/m	$0n/m	$0n/m	$0-100.0%	$484K

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$699.0M+4.2%	$1.1B+174.2%	$430.0M-40.9%	$535.0M-52.0%	$671.0M+156.1%	$418.0M	$727.0M+856.6%	$1.1Bn/m
Depreciation & Amortization	$39.0M-25.0%	$45.0M+60.7%	$35.0M+40.0%	$38.0M+123.5%	$52.0M+766.7%	$28.0M	$25.0M	$17.0M
Capital Expenditures	$11.0M+120.0%	$19.0M	$17.0M-43.3%	$20.0M-24.2%	$5.0M+8.0%	N/A	$30.0M-63.0%	$26.4M+66.8%
Free Cash Flow	$688.0M+3.3%	$1.1B	$413.0M-40.7%	$515.0M-52.7%	$666.0M+158.8%	N/A	$697.0Mn/m	$1.1Bn/m
Investing Cash Flow	-$4.3Bn/m	-$3.3Bn/m	-$3.3Bn/m	$2.6B-71.7%	-$5.7Bn/m	-$4.0B	-$1.1B-2412.5%	$9.2Bn/m
Financing Cash Flow	$889.0M-29.7%	$2.2B+103.6%	$2.4B+559.6%	$1.4B+8.9%	$1.3B+285.7%	$1.1B	$361.0M+48.6%	$1.3B-46.7%
Dividends Paid	$6.0M-68.4%	$8.0M-27.3%	$11.0M0.0%	$11.0M0.0%	$19.0Mn/m	$11.0M	$11.0M	$11.0M

Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.

ANG-PB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ANG-PB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Net Margin	7.1%-2.6pp	9.7%-1.9pp	11.6%	135.8%	15.0%-12.7pp	27.7%+20.6pp	7.1%-22.5pp	29.6%+25.1pp	4.5%+0.7pp	3.8%-10.7pp	14.5%+8.7pp	5.8%-3.9pp	9.7%+6.2pp	3.5%-3.4pp	6.9%
Return on Equity	5.5%-1.8pp	7.3%-5.7pp	13.0%-68.8pp	81.7%+74.6pp	7.1%-3.4pp	10.6%+5.0pp	5.6%-13.5pp	19.1%+12.9pp	6.1%+2.5pp	3.6%-7.7pp	11.3%+5.4pp	5.9%-12.4pp	18.3%+14.9pp	3.4%-2.8pp	6.1%
Return on Assets	0.4%-0.2pp	0.6%-0.5pp	1.1%-1.5pp	2.6%+1.9pp	0.7%-0.3pp	0.9%+0.6pp	0.4%-0.4pp	0.7%+0.5pp	0.3%+0.1pp	0.1%-0.3pp	0.4%+0.2pp	0.3%-0.4pp	0.6%+0.5pp	0.2%-0.1pp	0.3%
Debt-to-Equity	0.310.0x	0.29-0.2x	0.49	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	12.47+1.4x	11.09+1.2x	9.92-20.2x	30.14+20.7x	9.41-0.9x	10.29-4.4x	14.71-9.9x	24.63+3.9x	20.76-2.7x	23.46-0.8x	24.21+4.7x	19.56-8.1x	27.61+8.2x	19.42-1.5x	20.92
Asset Turnover	0.060.0x	0.060.0x	0.09+0.1x	0.020.0x	0.050.0x	0.030.0x	0.050.0x	0.030.0x	0.060.0x	0.040.0x	0.030.0x	0.050.0x	0.070.0x	0.050.0x	0.04
FCF Margin	36.3%+3.3pp	33.1%-0.4pp	33.5%	141.7%	114.2%	53.3%-43.3pp	96.6%+94.1pp	2.5%-46.8pp	49.3%-14.4pp	63.7%+30.6pp	33.1%+0.6pp	32.6%-0.4pp	33.0%-14.4pp	47.4%+25.6pp	21.9%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Net Margin	-0.1%+10.8pp	27.2%+9.7pp	10.6%+25.0pp	7.0%-5.1pp	-10.9%-17.7pp	17.5%	-14.4%-18.6pp	12.1%+5.3pp
Return on Equity	0.0%+2.0pp	3.8%-2.7pp	2.0%+4.9pp	1.5%-1.3pp	-2.1%-5.6pp	6.5%	-2.9%-5.5pp	2.8%-1.2pp
Return on Assets	0.0%+0.2pp	0.3%-0.3pp	0.2%+0.4pp	0.1%-0.1pp	-0.2%-0.3pp	0.5%	-0.2%-0.3pp	0.2%+0.1pp
Debt-to-Equity	0.310.0x	0.310.0x	0.310.0x	0.290.0x	0.29	0.29-0.2x	0.30	0.27
Liabilities-to-Equity	12.88+1.6x	12.47+1.4x	10.89-0.5x	11.37-0.4x	11.29-13.4x	11.09+1.2x	11.39-25.0x	11.81-17.4x
Asset Turnover	0.010.0x	0.010.0x	0.020.0x	0.020.0x	0.020.0x	0.03	0.020.0x	0.020.0x
FCF Margin	43.0%+7.7pp	83.2%	20.1%-14.7pp	23.6%-27.9pp	35.3%+19.9pp	N/A	34.8%+35.2pp	51.5%+70.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Where ANG-PB Ranks

Frequently Asked Questions

ANG-PB (ANG-PB) reported $7.5B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

ANG-PB (ANG-PB) revenue declined by 0.4% year-over-year, from $7.5B to $7.5B in fiscal year 2025.

Yes, ANG-PB (ANG-PB) reported a net income of $738.0M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net income of $533.0M, with a net profit margin of 7.1%.

As of fiscal year 2025, ANG-PB (ANG-PB) had $11.7B in cash and equivalents against $3.0B in long-term debt.

ANG-PB (ANG-PB) had a net profit margin of 7.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

ANG-PB (ANG-PB) has a return on equity of 5.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

ANG-PB (ANG-PB) generated $2.7B in free cash flow during fiscal year 2025. This represents a 9.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

ANG-PB (ANG-PB) generated $2.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

ANG-PB (ANG-PB) had $130.3B in total assets as of fiscal year 2025, including both current and long-term assets.

ANG-PB (ANG-PB) invested $61.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

ANG-PB (ANG-PB) had a debt-to-equity ratio of 0.31 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

ANG-PB (ANG-PB) had a liabilities-to-equity ratio of 12.47 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

ANG-PB (ANG-PB) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

ANG-PB (ANG-PB) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

ANG-PB (ANG-PB) has an earnings quality ratio of 5.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

ANG-PB Financials

The balance sheet expanded rapidly, but profitability weakened while cash generation improved and liabilities remained the dominant funding source.

Financial Health Signals

Key Financial Metrics

Earnings & Revenue

Cash & Balance Sheet

Margins & Returns

Capital Allocation

ANG-PB Income Statement

ANG-PB Balance Sheet

ANG-PB Cash Flow Statement

ANG-PB Financial Ratios

Where ANG-PB Ranks

Frequently Asked Questions

What is ANG-PB's annual revenue?

How fast is ANG-PB's revenue growing?

Is ANG-PB profitable?

How much debt does ANG-PB have?

What is ANG-PB's net profit margin?

What is ANG-PB's return on equity (ROE)?

What is ANG-PB's free cash flow?

What is ANG-PB's operating cash flow?

What are ANG-PB's total assets?

What are ANG-PB's capital expenditures?

What is ANG-PB's debt-to-equity ratio?

What is ANG-PB's liabilities-to-equity ratio?

What is ANG-PB's return on assets (ROA)?

What is ANG-PB's Piotroski F-Score?

Are ANG-PB's earnings high quality?